transcatheter aortic valve replacement | Page 22 of 28

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 28 November, 2025 0

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 27 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 26 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: transcatheter aortic valve replacement

Cardiovascular MR Perfusion Imaging: Good Initial Alternative in Stable Chronic Angina

TAVI Frailty Indices: We Should Start Using Them

Pacing with a 0.035” Guidewire, an Old Technique Coming Back to...

Cerebral Protection in TAVR: Does It Improve Cognitive Function?

Meta-analysis on Cerebral Embolic Protection in TAVR

Evolut R: Clinical Results Might Be Better than Those for First-Generation...

Post-Dilation of Self-Expanding Valves: Frequency, Usefulness, and Risks

Asymptomatic Severe Aortic Stenosis in the Elderly: When to Intervene

TAVR: Reasons to Consider Mitral Annular Calcification

4 Readmission Predictors after Successful TAVR

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos